Dr. Mariam Gamaleldin

Dr. Mariam Gamaleldin started her academic career by acquiring a BSc in Pharmacy and Biotechnology from the German University in Cairo. As an undergraduate pharmacist, she found herself attracted towards cell biology, molecular biology, biochemistry, pharmacology and their applications. She kickstarted her research career with an undergraduate internship at Cold Spring Harbor Laboratory in New York. After her graduation, she relocated to Germany, where she did a MSc degree in Life Science at the Julius Maximilian University of Würzburg. Her MSc thesis, at the Institute of Pharmacology and Toxicology, aimed at unraveling the unusual mechanisms of Opioid receptor signaling by means of FRET microscopy and cell culture. Wanting to understand the influence of receptors on neurobiology and behavior, she went on to do her PhD at the Danish Research Institute of Translational Neuroscience (DANDRITE) in Aarhus University, Denmark, where she collaboratively developed a novel proteomic technique to determine which newly synthesized proteins are required for synaptic potentiation, and ultimately, memory. She also did research stays at renowned institutions, such as Mayo Clinic in Florida and the Scripps Research Institute in California. Dr. Mariam’s diverse educational and research background enabled her to teach courses in Germany and Denmark, such as the “Topics and Methods in Life Science” and “Molecular Processes in the Cell”. She also strives to support researchers and science communicators through her participation in the Story Collider’s Brave Space for BIPOC science communicators.

 

 

Dr. Mohamed Nagy

Mohamed Nagy is the Pharmacy Director and the founder of the Personalized Medication Management Unit at the Children’s Cancer Hospital 57357. He is a clinical instructor at Colorado university school of pharmacy.

Mohamed Nagy earned his master’s degree in Biotechnology from the American University in Cairo, where he studied how certain genetic polymorphisms increase risk of thrombosis in Egyptian patients suffering from Acute lymphocytic leukemia (ALL). Mohamed is considered one of the Experts in clinical pharmacogenomics and Nutrigenomics in Middle East and Africa. He dedicated his genetic knowledge not only to patients but also to allow healthy individuals to find the best sports and nutrition routine tailored to their unique individual genetic makeup in order to achieve the best health outcomes. Mohamed is an instructor of Nutrigenomics at Tanta University Nutrition Diploma.

Mohamed is a founder in Pharmacogenomics Access & Reimbursement Coalition (PARC) and he is also a founder of the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE). Currently, Mohamed is leading the Pharmacogenomics Research Network Developing Countries Committee for the area of Middle East and Africa. Finally, he is the Leader of IVPN Personalized Medicine Listserv.